VitriLife® is the 1st scalable vitrification platform designed for the long-term ambient temperature stabilization of microbial and biological materials. ​

​

• Designed as a more efficient, scalable, and cost-effective alternative to lyophilization resulting in superior stabilization for real world environments.
   

• Immobilizes biological materials in a sugar glass matrix.

​

• Arrests rotational and translational motion of molecules.

​

• Achieves significant increases to product shelf life and improves activity yields.

​

• Maintains higher titer after drying and subsequent storage.

​

• Reduces logistical burden of cold chain, packaging, and shipping costs.

​

• Enables micronization (milling foam to powder) without product damage.

​

• Enables formulation of combination/multi-component products. ​
   

• Instantaneous reconstitution at site of delivery.

​

• The cornerstone of the VitriLife platform is our patented state-of-the-art drying by boiling process known as preservation by vaporization (PBV).   

​

Expertise in the stabilization and delivery of a wide range of biologics such as: ​

​

• Vaccines (e.g. mRNA, live viral and bacterial vaccines)

• Therapeutic Proteins

• Microbiome Therapeutics 

• Probiotics

• Agricultural Biologicals (e.g. bacteria, fungi)

• Enzymes 

and much more...

How does VitriLife technology compare against other drying technologies?

VitriLife technology allows the scalable production of thermostable vaccines and other biologics in vials and/or in bulk format